Basal Cell Carcinoma

a.k.a. Basal cell epitheliomais a cancer that originates in cells of the epidermis most common skin cancer slow growing form of skin cancer non-melanoma skin cancer

Body distribution of BCCs is as follows:• On the head (most frequently on the face; most common location is the nose, specifically the nasal tip and alae) - 70%•On the trunk- 25%•On the penis, vulva, or perianal skin - 5%

Risk Factors:• Radiation• Men•55-75 year-old age group• Family history• Exposure to carcinogens• Previous history of non-melanoma skin cancer• White

Sign and symptoms1. Noduloulcerative lesions

usually occur on the face, particularly the forehead, eyelid margins, and nasolabial folds.

Most common type Nodulocystic structure that

begins as a small, flesh- colored or pink, smooth, translucent nodule that enlarges with time.

Early stages:• small, smooth, pinkish and translucent papules.• telangiectatic vessels cross the surface, and the lesions are occasionally pigmented.• ulceration and local invasion

2. Superficial basal cell epitheliomas• Chest and back• oval or irregularly shaped

lightly pigmented plaques with sharply defined slightly elevated threadlike borders.

• Chronic and tend to invade other areas

• related to ingestion or exposure to arsenic- containing compounds

3. Sclerosing basal cell epitheliomas• Head and neck•Waxy, sclerotic, yellow to white plaques without distinct borders•Commonly look like small patches of scleroderma

 

• Complication:- Disfigurement- Death

• Prognosis:- usually good because

the tumor remain localized

Medical Management:• Mohs’ Micrographic Surgery

is the most recommended tissue- sparing procedureTreatment of choice for tumors around the eyes, nose, upperlip, and auricular and periauricular areas

•Surgical management•Electrosurgery•Cryosurgery•Radiation theraphy

Nursing Management:• Teaching patients self care• Teaching about prevention